These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 3089539)
61. Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridinium (MPP+) and not blocked by deprenyl. Fuller RW; Hemrick-Luecke SK Life Sci; 1986 Nov; 39(18):1645-50. PubMed ID: 3095601 [TBL] [Abstract][Full Text] [Related]
63. Histochemical localization of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine oxidation in the mouse brain. Vincent SR Neuroscience; 1989; 28(1):189-99. PubMed ID: 2569695 [TBL] [Abstract][Full Text] [Related]
64. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion. Mytilineou C; Cohen G J Neurochem; 1985 Dec; 45(6):1951-3. PubMed ID: 3932598 [TBL] [Abstract][Full Text] [Related]
65. A study of the biological pharmacology of IFO, a new selective and reversible monoamine oxidase-B inhibitor. Matsumoto J; Takahashi T; Agata M; Toyofuku H; Sasada N Jpn J Pharmacol; 1994 May; 65(1):51-7. PubMed ID: 8089930 [TBL] [Abstract][Full Text] [Related]
66. The interactions of monoamine oxidase with some derivatives of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Sullivan JP; Tipton KF J Neural Transm Suppl; 1990; 29():269-77. PubMed ID: 2358804 [TBL] [Abstract][Full Text] [Related]
68. Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessary. Gibb C; Willoughby J; Glover V; Sandler M; Testa B; Jenner P; Marsden CD Neurosci Lett; 1987 May; 76(3):316-22. PubMed ID: 3495757 [TBL] [Abstract][Full Text] [Related]
69. Difference in monoamine oxidase B activity between C57 black and albino NMRI mouse strains may explain differential effects of the neurotoxin MPTP. Zimmer J; Geneser FA Neurosci Lett; 1987 Aug; 78(3):253-8. PubMed ID: 3498133 [TBL] [Abstract][Full Text] [Related]
70. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Chiba K; Trevor A; Castagnoli N Biochem Biophys Res Commun; 1984 Apr; 120(2):574-8. PubMed ID: 6428396 [TBL] [Abstract][Full Text] [Related]
71. Novel 4-(aryloxy)tetrahydropyridine analogs of MPTP as monoamine oxidase A and B substrates. Kalgutkar AS; Castagnoli K; Hall A; Castagnoli N J Med Chem; 1994 Apr; 37(7):944-9. PubMed ID: 8151621 [TBL] [Abstract][Full Text] [Related]
72. Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse. Sundström E; Jonsson G Eur J Pharmacol; 1985 Apr; 110(3):293-9. PubMed ID: 3874083 [TBL] [Abstract][Full Text] [Related]
73. Comparison of intra- and extrasynaptosomal monoamine oxidase-A and -B activities in the striatum and frontal cortex of two mice strains with different sensitivities to the neurotoxic actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Stenström A; Sundström E; Fowler CJ Pharmacol Toxicol; 1989 Mar; 64(3):276-81. PubMed ID: 2786196 [TBL] [Abstract][Full Text] [Related]
74. Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Peterson LA; Caldera PS; Trevor A; Chiba K; Castagnoli N J Med Chem; 1985 Oct; 28(10):1432-6. PubMed ID: 3876442 [TBL] [Abstract][Full Text] [Related]
75. Molecular determinants in the bioactivation of the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Efange SM; Boudreau RJ J Comput Aided Mol Des; 1991 Oct; 5(5):405-17. PubMed ID: 1685185 [TBL] [Abstract][Full Text] [Related]
76. Depletion of heart norepinephrine in mice by some analogs of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). Fuller RW; Hemrick-Luecke SK Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):147-56. PubMed ID: 3496637 [TBL] [Abstract][Full Text] [Related]
78. Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro. Danias P; Nicklas WJ; Ofori S; Shen J; Mytilineou C J Neurochem; 1989 Oct; 53(4):1149-55. PubMed ID: 2788714 [TBL] [Abstract][Full Text] [Related]
79. Strain differences in systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier. Riachi NJ; Harik SI Life Sci; 1988; 42(23):2359-63. PubMed ID: 3259663 [TBL] [Abstract][Full Text] [Related]
80. N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change. Shin EJ; Nam Y; Lee JW; Nguyen PT; Yoo JE; Tran TV; Jeong JH; Jang CG; Oh YJ; Youdim MBH; Lee PH; Nabeshima T; Kim HC Mol Neurobiol; 2016 Nov; 53(9):6251-6269. PubMed ID: 26563498 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]